Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 13,876 | $0.00 Strike: $14.65 | $0.00 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · derivative · entry 6 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,876 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2012 F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. F4 · balance_after: This option was previously reported as covering 6,647 shares at an exercise price of $33.85 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,938 shares of common stock at an exercise price of $29.29 per share. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 15,658 | $0.00 Strike: $14.65 | $0.00 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · derivative · entry 5 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,876 Underlying: Common Stock · 15,658 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2012 F2 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $33.85 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $29.29 per share. F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionCommon Stock | 13,876 | $14.65 | $203,214.02 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionCommon Stock | 15,658 | $14.65 | $229,311.41 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,404 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · derivative · entry 7 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,404 Underlying: Common Stock · 3,404 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 99 | $43.39 | $4,295.61 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 6 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,958 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 96 | $43.39 | $4,165.44 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 5 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,057 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
GrantCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,153 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 102 | $43.39 | $4,425.78 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,471 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 42 | $43.39 | $1,822.38 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,573 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 193 | $43.39 | $8,374.27 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,615 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 19,340 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · derivative · entry 10 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,340 Underlying: Common Stock · 19,340 shares Expires 2028-03-13 F2 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 445 | $43.39 | $19,308.55 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 9 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 612 | $43.39 | $26,554.68 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 8 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,918 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 476 | $43.39 | $20,653.64 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 7 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,530 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
GrantCommon Stock | 3,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,006 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 184 | $43.39 | $7,983.76 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 5 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,134 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 196 | $43.39 | $8,504.44 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,318 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 164 | $43.39 | $7,115.96 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,514 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,361 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · derivative · entry 8 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,361 Underlying: Common Stock · 10,361 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 393 | $43.39 | $17,052.27 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 7 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,930 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 269 | $43.39 | $11,671.91 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 6 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 260 | $43.39 | $11,281.40 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 5 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,592 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
GrantCommon Stock | 2,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 4 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,852 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 108 | $43.39 | $4,686.12 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 3 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,777 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 111 | $43.39 | $4,816.29 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 2 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,885 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:14 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 105 | $43.39 | $4,555.95 |
DisclosureSEC source: 0001209191-20-019561 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,996 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:15 UTC |
Schwartz EricCorp VP, Gen Counsel & Sec
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,390 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019564 · doc4.xml · derivative · entry 4 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,390 Underlying: Common Stock · 14,390 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:15 UTC |
Schwartz EricCorp VP, Gen Counsel & Sec
|
Tax withholdingCommon Stock | 434 | $43.39 | $18,831.26 |
DisclosureSEC source: 0001209191-20-019564 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,212 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:15 UTC |
Schwartz EricCorp VP, Gen Counsel & Sec
|
GrantCommon Stock | 2,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019564 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,646 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:15 UTC |
Schwartz EricCorp VP, Gen Counsel & Sec
|
Tax withholdingCommon Stock | 179 | $43.39 | $7,766.81 |
DisclosureSEC source: 0001209191-20-019564 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,765 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
Anderson Carrie LCVP, Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 28,780 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019559 · doc4.xml · derivative · entry 2 Anderson Carrie L · CIK 0001706446 · CVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,780 Underlying: Common Stock · 28,780 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
Anderson Carrie LCVP, Chief Financial Officer
|
GrantCommon Stock | 5,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019559 · doc4.xml · nonDerivative · entry 1 Anderson Carrie L · CIK 0001706446 · CVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,437 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,887 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · derivative · entry 8 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,887 Underlying: Common Stock · 15,887 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 1,121 | $43.39 | $48,640.19 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 7 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,735 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 570 | $43.39 | $24,732.30 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 6 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,856 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 547 | $43.39 | $23,734.33 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 5 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,426 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
GrantCommon Stock | 3,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,973 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 226 | $43.39 | $9,806.14 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,792 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 235 | $43.39 | $10,196.65 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,018 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:12 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 300 | $43.39 | $13,017.00 |
DisclosureSEC source: 0001209191-20-019557 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,253 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 43,746 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · derivative · entry 8 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,746 Underlying: Common Stock · 43,746 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 2,300 | $43.39 | $99,797.00 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 7 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,894 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 1,568 | $43.39 | $68,035.52 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 6 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,194 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 1,211 | $43.39 | $52,545.29 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 5 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,762 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
GrantCommon Stock | 8,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 4 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,973 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 719 | $43.39 | $31,197.41 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 3 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,215 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 751 | $43.39 | $32,585.89 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,934 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 883 | $43.39 | $38,313.37 |
DisclosureSEC source: 0001209191-20-019552 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,685 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:09 UTC |
Arduini Peter JDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 41,485 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019550 · doc4.xml · derivative · entry 14 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,415 Underlying: Common Stock · 41,485 shares Expires not disclosed F5 · derivative.exercise_price: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2020 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F5 · derivative.exercise_date: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2020 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F5 · derivative.expiration_date: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2020 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.